Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
about
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6DApproaches for estimating minimal clinically important differences in systemic lupus erythematosusIdentifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia.Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.Health-related quality of life, mood, and patient satisfaction after epilepsy surgery in Sweden--a prospective controlled observational study.Yoga for persistent fatigue in breast cancer survivors: results of a pilot study.The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practiceNeurocognitive functioning and quality of life in patients with recurrent malignant gliomas treated on a phase Ib trial evaluating topotecan by convection-enhanced deliveryMethods for analyzing psychotherapy outcomes: a review of clinical significance, reliable change, and recommendations for future directions.The CREATE Method for Expressing Continuous Outcome Data in Absolute Terms for Use in Patient Treatment Decision Aids: A Validation Study.Evaluating the statistical significance of health-related quality-of-life change in individual patients.Issues in selecting outcome measures to assess functional recovery after stroke.Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial.Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes.The meaning of it all: evaluating knowledge of Minimal Clinically Important Difference (MCID) among chiropractic studentsSelf-rated health and long-term prognosis of depression.Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trial.Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia.A systematic review of intermittent pneumatic compression for critical limb ischaemia.A resilience intervention involving mindfulness training for transplant patients and their caregivers.Social position modifies the association between severe shoulder/arm and knee/leg pain, and quality of life after retirement.Statistical approaches to analyse patient-reported outcomes as response variables: an application to health-related quality of life.Change in Health-Related Quality-of-Life at Group and Individual Levels Over Time in Patients Treated for Chronic Myofascial Neck Pain.Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study.Psychometric properties of the UCLA PTSD reaction index: part I.Weight loss in overweight patients maintained on atypical antipsychotic agents.Evaluating clinically significant changes in health-related quality of life: A sample of relatives of patients with severe traumatic brain injury.Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes.Change in health‐related quality of life of opiate users in low‐threshold methadone programs
P2860
Q24796975-CB2BB440-7068-467E-8E1A-878070585D2BQ27021623-7D558D5F-6216-444A-981B-0B4F4FB46611Q33758444-C99CC1C0-D4DB-47F8-B830-3F32B806D6CFQ34225234-CF21DD88-5A29-42DB-AAAC-980E13C6CA15Q34516530-285A215F-97D1-45D0-A6F7-2BF6420F9A60Q34521338-2FA394B9-5BCD-491B-A058-5149E20CF44BQ35163376-F044DF97-07AD-4E39-9865-7982981ECB20Q35206202-B582C66C-957C-4975-8E05-26B62BE92B8EQ35673863-8036F6A3-A387-4249-A117-2B399451A5C8Q35738442-67F82D8E-EEB1-4559-93F8-79C41574EA7FQ36106157-1B579D7B-633A-4024-A8E0-6CF92DEF22C0Q36608827-D1A60F82-642F-4D41-A59F-F8C91A8414F0Q36696178-4188F863-FB0E-4DD0-AC37-ECD616FBB006Q37250961-2917D2A8-1363-485C-8178-D60AB99CD34EQ37291500-1C916DFE-4C7A-4BAD-82FB-3DBDC2E0D84DQ37496387-2B6C4F25-8229-4634-9BA7-FFC16E73956DQ37638644-A965534C-EDDC-46E6-A885-18110ACE1609Q37892489-1CF6DD71-14CB-4EE9-8458-1DA0555E92E8Q38255706-63192E37-1220-498D-9364-AB4642653919Q39297006-40F11809-C8C0-4AB3-9004-B02CAD9BB2D4Q41002640-BA1D999D-2EA9-4E7C-A362-F81C8A3DB703Q44002272-68C86914-2103-456D-9E8F-048D9C46C42EQ44586129-3EDE49D6-8091-4EA9-A46F-03C1AB710872Q45329955-4EDCF120-194E-48FA-96FE-6CD20FEA4429Q46111429-450ED8A0-97F5-4E26-A16A-C0EC8EC9CE98Q46908179-D40E1B3C-9422-401E-B9F4-42599106F65CQ47655904-72027311-BA2D-496A-868D-CF9D3FEF875EQ48352335-2BDDBA05-9284-4C53-A6F6-D91F07B368B2Q57998557-F25E5159-7EA5-4951-A5D9-FAE37319C1B1
P2860
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
@en
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
@nl
type
label
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
@en
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
@nl
prefLabel
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
@en
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
@nl
P2093
P356
P1476
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.
@en
P2093
Amy B Robinson
Mark Splaine
Robert J Ferguson
P2888
P304
P356
10.1023/A:1016350431190
P577
2002-09-01T00:00:00Z
P6179
1036417910